[1]王智芳,黄建乐△.祛风宣痹方联合孟鲁司特钠治疗过敏性鼻炎哮喘综合征临床研究*[J].陕西中医,2020,(5):629-631,642.[doi:DOI:10.3969/j.issn.10007369.2020.05.021]
　WANG Zhifang,HUANG Jianle..Clinical effect of Qufeng Xuanbi decoction combined with montelukast sodium in the treatment of allergic rhinitis and asthma syndrome[J].,2020,(5):629-631,642.[doi:DOI:10.3969/j.issn.10007369.2020.05.021]
点击复制

祛风宣痹方联合孟鲁司特钠治疗过敏性鼻炎哮喘综合征临床研究*
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2020年5期
页码:
629-631,642
栏目:
临床研究
出版日期:
2020-05-05

文章信息/Info

Title:
Clinical effect of Qufeng Xuanbi decoction combined with montelukast sodium in the treatment of allergic rhinitis and asthma syndrome
作者:
王智芳; 黄建乐△
长沙市中心医院中西医结合科(长沙 410000)
Author(s):
WANG Zhifang; HUANG Jianle.
Department of Integration of Chinese and Western Medicine,Changsha Central Hospital(Changsha 410000)
关键词:
过敏性鼻炎;  哮喘;  祛风宣痹方;  孟鲁司特钠;  Th1/Th2细胞;  疗效
Keywords:
Allergic rhinitis;  Asthma;  Qufeng Xuanbi decoction;  Montelukast sodium;  Th1/Th2 cells;  Efficacy
分类号:
R562.25
DOI:
DOI:10.3969/j.issn.10007369.2020.05.021
文献标志码:
A
摘要:
目的:探讨自拟祛风宣痹方联合孟鲁司特钠治疗过敏性鼻炎哮喘综合征(CARAS)的疗效及对血清Th1/Th2细胞因子的影响。方法:选取CARAS患儿108例,采用随机数字表法分为对照组和观察组,各54例。对照组给予布地奈德福莫特罗、孟鲁司特钠治疗,观察组在对照组基础上给予自拟祛风宣痹方治疗。比较两组临床疗效,治疗前后鼻炎及哮喘症状评分,血清TNF-β、IFN-γ、IL-4、IL-5指标水平变化。结果:治疗后两组中医症状积分均明显下降,且观察组比对照组下降更明显(P<0.05)。观察组临床控制率83.33%高于对照组62.96%(P<0.05),两组总有效率比较(观察组98.15%与对照组94.44%)差异无统计学意义(P>0.05); 两组治疗前鼻炎、哮喘症状评分,血清TNF-β、IFN-γ、IL-4、IL-5比较差异无统计学意义(P>0.05); 治疗后,两组TNF-β、IFN-γ均升高,IL-4、IL-5、鼻炎及哮喘症状评分均降低(P<0.05); 观察组治疗后TNF-β、IFN-γ均高于对照组,IL-4、IL-5、鼻炎及哮喘症状评分均低于对照组(P<0.05)。治疗期间,两组患儿均未出现明显的不良反应情况(P>0.0.5)。结论:祛风宣痹方联合孟鲁司特钠可显著改善CARAS临床症状,调节Th1/Th2平衡,临床疗效确切。
Abstract:
Objective:To investigate the efficacy of Qufeng Xuanbi decoction combined with montelukast sodium in the treatment of allergic rhinitis and asthma syndrome(CARAS)and its effect on serum Th1/Th2 cytokines.Methods:108 children with CARAS were selected.Randomly divided into control group and observation group,54 cases each.The control group was treated with budesonide,formoterol and montelukast sodium,and the observation group was treated with Qufeng Xuanbi decoction on the basis of the control group.The clinical effect,the score of rhinitis and asthma,the changes of serum TNF-β,IFN-γ,IL-4 and IL-5 were compared before and after treatment.Results:After treatment,the TCM symptom scores of the two groups decreased significantly,and the observation group decreased more significantly than the control group(P<0.05).The clinical control rate of the observation group was 83.33% higher than that of the control group(62.96%)(P<0.05).There was no significant difference in the total effective rate between the two groups(98.15% in the observation group and 94.44% in the control group)(P>0.05).There was no significant difference in the scores of rhinitis and asthma symptoms,serum TNF-β,IFN-γ,IL-4 and IL-5 between the two groups before and after treatment(P>0.05).The scores of TNF- β and IFN- γ in the observation group were higher than those in the control group,and the scores of IL-4,IL-5,rhinitis and asthma were lower than those in the control group(P<0.05).During the treatment,there was no significant adverse reaction in the two groups(P>0.5).Conclusion:Qufeng Xuanbi decoction combined with montelukast sodium can significantly improve the clinical symptoms of CARAS,regulate the balance of Th1/Th2,have a definite clinical effect.

参考文献/References:

[1] 陈俏容,刘国钧,刘胜华,等.不同途径吸入布地奈德气雾剂治疗儿童过敏性鼻炎哮喘综合征的临床效果对比[J].中国医药导报,2016,389(3):116-119.
[2] 王麒淇,张 旭,王向东,等.过敏性鼻炎伴哮喘综合征患者细胞分裂周期相关蛋白 5 基因表达和临床意义[J].中国耳鼻咽喉头颈外科,2019,26(8):441.
[3] 江瑾玥,郭述良.256例过敏性鼻炎-哮喘综合征问卷调查分析[J].国际呼吸杂志,2017,37(7):512-515.
[4] 张小朴,史锁芳.中医药治疗过敏性鼻炎-哮喘综合征研究概况[J].中国中医急症,2015,24(1):114-116.
[5] 中华耳鼻咽喉头颈外科杂志编辑委员会鼻科组,中华医学会耳鼻咽喉头颈外科学分会鼻科学组.变应性鼻炎诊断和治疗指南(2015年,天津)[J].中华耳鼻咽喉头颈外科杂志,2016,51(1):6-24.
[6] 中华医学会儿科学分会呼吸学组,《中华儿科杂志》编辑委员会.儿童支气管哮喘诊断与防治指南(2016年版)[J].中华儿科杂志,2016,54(3):167-181.
[7] 国家食品药品监督管理总局.中药新药临床研究指导原则:试行[J].北京:中国医药科技出版社,2002:77-85.
[8] 王和生,周 姗,刘兰英,等.穴位贴敷对合并过敏性鼻炎的哮喘缓解期血清 miRNAs 影响的研究[J].针灸临床杂志,2016,32(12):1-4.
[9] 彭 博,刘兰英,王和生,等.咳喘停药贴对过敏性鼻炎-哮喘综合征患者 IFN-γ/IL-4 的影响[J].辽宁中医杂志,2018,45(2):343-345.
[10] 李彩虹,龚 莹.肾病综合征合并支气管哮喘22例临床分析[J].陕西医学杂志,2015,44(7):831-832.
[11] 王淑玉,郑一博,吕朝霞.特异性免疫治疗对儿童过敏性鼻炎-哮喘综合征的效果观察[J].解放军医药杂志,2016,28(10):65-68.
[12] 汪文娟,司峰志.探究特异性免疫治疗对过敏性鼻炎-哮喘综合征儿童的临床效果和肺功能改善情况[J].名医,2019,71(4):51-53.
[13] 姜伟洲,韩克华,于乐泳,等.补肾疏风法对伴发过敏性鼻炎的支气管哮喘患者体质干预的影响[J].光明中医,2018,33(2):163-165.
[14] 史锁芳,王德钧,杨继兵,等.益气祛风、宣痹化饮方治疗过敏性鼻炎哮喘综合征的临床观察[J].中国中医急症,2016,25(5):921-924.
[15] 邓 玫.黄芪颗粒治疗过敏性鼻炎哮喘综合征患儿的疗效及对血清Th1、Th2细胞因子的影响[J].中医药学报,2017,45(2):68-71.
[16] 李 欣,张 巍,申东东,等.止咳平喘方治疗婴幼儿哮喘疗效及对患儿外周血树突细胞共刺激分子的影响[J].陕西中医,2019,40(9):1170-1173.

相似文献/References:

[1]石德祥,张美丽△.鼻炎康片联合曲安奈德穴位注射治疗过敏性鼻炎疗效及对患者生活质量影响[J].陕西中医,2019,(10):1431.
[2]房娟,任亮,张建鹏,等.疏风通窍汤联合富马酸卢帕他定治疗过敏性鼻炎临床研究[J].陕西中医,2019,(11):1590.
　FANG Juan,REN Liang,ZHANG Jianpeng,et al.Shufeng Tongqiao decoction combined with rupatadine fumarate in the treatment of allergic rhinitis[J].,2019,(5):1590.
[3]赵 茜,吴佳丽,余文丽,等.清热润燥方对哮喘小鼠气道反应及炎性反应影响的实验研究*[J].陕西中医,2020,(12):1695.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.004]
　ZHAO Qian,WU Jiali,YU Wenli,et al.Experimental study on the effect of Qingre Runzao recipe on airway reaction and inflammatory reaction in asthmatic mice[J].,2020,(5):1695.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.004]
[4]李竹英,陈 璐,王丽洁.麻黄-白果药对“异病同治”支气管哮喘和慢性阻塞性肺疾病药理作用研究[J].陕西中医,2021,(8):1128.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.035]
　LI Zhuying,CHEN Lu,WANG Lijie.Pharmacological mechanism of Ephedra and Ginkgo couplet medicine in treating asthma and COPD based on treating different diseases with the same treatment[J].,2021,(5):1128.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.035]
[5]刘顺利,梁萌萌,刘大英,等.黄芪多糖对过敏性鼻炎大鼠Treg/Th17细胞免疫平衡和炎症因子的影响[J].陕西中医,2023,(1):20.[doi:DOI:10.3969/j.issn.1000-7369.2023.01.005]
　LIU Shunli,LIANG Mengmeng,LIU Daying,et al.Effects of astragalus polysaccharides on immune balance and inflammatory factors of Treg/Th17 cells in a rat of allergic rhinitis[J].,2023,(5):20.[doi:DOI:10.3969/j.issn.1000-7369.2023.01.005]
[6]沈毅韵,朱一冰,张艳涛,等.肺脾肾湿论治小儿过敏性鼻炎作用机制研究进展[J].陕西中医,2023,(1):133.[doi:DOI:10.3969/j.issn.1000-7369.2023.01.033]
　SHEN Yiyun,ZHU Yibing,ZHANG Yantao,et al.Research progress on the mechanism of treating allergic rhinitis in children with the theory of lung,spleen and kidney dampness[J].,2023,(5):133.[doi:DOI:10.3969/j.issn.1000-7369.2023.01.033]
[7]王媛媛,王桂玲,耿雨作,等.黄芪多糖通过TGF-β1/Smads通路对哮喘大鼠Th1/Th2免疫失衡的调节作用[J].陕西中医,2024,(9):1181.[doi:DOI:10.3969/j.issn.1000-7369.2024.09.006]
　WANG Yuanyuan,WANG Guiling,GENG Yuzuo,et al.Effects of Astragalus polysaccharide on Th1/Th2 immune imbalance in asthmatic rats through TGF-β1/Smads pathway[J].,2024,(5):1181.[doi:DOI:10.3969/j.issn.1000-7369.2024.09.006]
[8]冯逸杰,郭新荣,晁姣姣,等.郭新荣基于“疏通调补”学术思想针药结合治疗过敏性鼻炎经验[J].陕西中医,2024,(10):1399.[doi:DOI:10.3969/j.issn.1000-7369.2024.10.023]

备注/Memo

备注/Memo:
*湖南省中医药管理局科研项目(201890)
更新日期/Last Update: 2020-05-14